https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/accounts-payable https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/accounts-receivable https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/accrued-liabilities-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/accumulated-depreciation https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/additional-paid-in-capital https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/advances-on-inventory-purchases https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/amended-reports-10-k https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/amended-reports-10-q https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/amortization https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/aoci https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/asset-impairment-charges https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/assets-noncurrent https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/capital-expenditures https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/cash https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/cash-change https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/cash-flow-breakdown https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/common-stock-value https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/comprehensive-income https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/cost-of-goods-sold https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/current-assets https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/current-liabilities https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-impairment-losses https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deposits-assets https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deposits-assets-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/depreciation https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/depreciation-and-amortization https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/due-from-related-parties-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/due-from-related-parties-noncurrent https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/due-to-related-parties-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/financing-cash-flow https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/foreign-pretax-income https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/general-and-administrative-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/gross-profit https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/income-tax https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/income-taxes-paid https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/interest-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/interest-expense-related-party https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/interest-paid https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/inventory https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/inventory-work-in-process-and-raw-materials-net-of-reserves https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/investing-cash-flow https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/marketing-and-advertising-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/minority-interest-ownership-percentage-by-parent https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/net-income https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/operating-cash-flow https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/operating-expenses https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/operating-income https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/other-general-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/other-income https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/other-noncash-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/preferred-shares-facts https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/preferred-stock-value https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/prepaid-expense-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/pretax-income-domestic https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/property-plant-equipment https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/public-float https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/related-party-transaction-due-from-to-related-party-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/rental-income-nonoperating https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/retained-earnings https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-10-k https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-10-q https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-10ksb https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-8-k https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-def-14c https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-ntn-10k https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-revoked https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/selling-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/shareholders-equity https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/shares-authorized https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/shares-issued https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/stock-based-compensation https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/stock-issued-shares-issued-value-employee-benefit-plan https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/tax-rate-reconciliation-tax-settlements https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/taxes-payable-current https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/total-assets https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/tongli-pharmaceuticals-usa-inc/weighted-average-number-of-share-outstanding-basic-and-diluted